Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Robert Martuza

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Procedures

Chemicals & Drugs

Genetic Vectors

Physiology

Anatomy

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Stankovic Konstantina M; Mrugala Maciej M; Martuza Robert L; Silver Michael; Betensky Rebecca A; Nadol Joseph B; Stemmer-Rachamimov Anat O
Genetic determinants of hearing loss associated with vestibular schwannomas.
Passer B J; Castelo-Branco P; Buhrman J S; Varghese S; Rabkin S D; Martuza R L
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Wakimoto Hiroaki; Kesari Santosh; Farrell Christopher J; Curry William T; Zaupa Cecile; Aghi Manish; Kuroda Toshihiko; Stemmer-Rachamimov Anat; Shah Khalid; Liu Ta-Chiang; Jeyaretna Deva S; Debasitis Jason; Pruszak Jan; Martuza Robert L; Rabkin Samuel D
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Martuza (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Stankovic Konstantina M; Mrugala Maciej M; Martuza Robert L; Silver Michael; Betensky Rebecca A; Nadol Joseph B; Stemmer-Rachamimov Anat O
Genetic determinants of hearing loss associated with vestibular schwannomas.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2009;30(5):661-7.
2009: Passer B J; Castelo-Branco P; Buhrman J S; Varghese S; Rabkin S D; Martuza R L
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Cancer gene therapy 2009;16(7):551-60.
2009: Wakimoto Hiroaki; Kesari Santosh; Farrell Christopher J; Curry William T; Zaupa Cecile; Aghi Manish; Kuroda Toshihiko; Stemmer-Rachamimov Anat; Shah Khalid; Liu Ta-Chiang; Jeyaretna Deva S; Debasitis Jason; Pruszak Jan; Martuza Robert L; Rabkin Samuel D
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
Cancer research 2009;69(8):3472-81.
2009: Sasportas Laura S; Kasmieh Randa; Wakimoto Hiroaki; Hingtgen Shawn; van de Water Jeroen A J M; Mohapatra Gayatry; Figueiredo Jose Luiz; Martuza Robert L; Weissleder Ralph; Shah Khalid
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(12):4822-7.
2009: Aghi Manish K; Carter Bob S; Cosgrove Garth R; Ojemann Robert G; Amin-Hanjani Sepideh; Martuza Robert L; Curry William T; Barker Fred G
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Neurosurgery 2009;64(1):56-60; discussion 60.
2009: Aghi Manish K; Liu Ta-Chiang; Rabkin Samuel; Martuza Robert L
Hypoxia enhances the replication of oncolytic herpes simplex virus.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(1):51-6.
2008: Farrell Christopher J; Zaupa Cecile; Barnard Zachary; Maley Jason; Martuza Robert L; Rabkin Samuel D; Curry William T
Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7711-6.
2008: Farassati Faris; Pan Weihong; Yamoutpour Farnaz; Henke Susann; Piedra Mark; Frahm Silke; Al-Tawil Said; Mangrum Wells I; Parada Luis F; Rabkin Samuel D; Martuza Robert L; Kurtz Andreas
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
The American journal of pathology 2008;173(6):1861-72.
2008: Liu Ta-Chiang; Castelo-Branco Pedro; Rabkin Samuel D; Martuza Robert L
Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(6):1041-7.
2008: Sher David J; Henson John W; Avutu Bindu; Hochberg Fred H; Batchelor Tracy T; Martuza Robert L; Barker Fred G; Loeffler Jay S; Chakravarti Arnab
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
Journal of neuro-oncology 2008;88(1):43-50.
2007: Fulci Giulia; Dmitrieva Nina; Gianni Davide; Fontana Elisabeth J; Pan Xiaogang; Lu Yanhui; Kaufman Claire S; Kaur Balveen; Lawler Sean E; Lee Robert J; Marsh Clay B; Brat Daniel J; van Rooijen Nico; Stemmer-Rachamimov Anat O; Hochberg Fred H; Weissleder Ralph; Martuza Robert L; Chiocca E Antonio
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.
Cancer research 2007;67(19):9398-406.
2007: Varghese Susan; Rabkin Samuel D; Nielsen G Petur; MacGarvey Usha; Liu Renbin; Martuza Robert L
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
Cancer research 2007;67(19):9371-9.
2007: Liu Ta-Chiang; Wakimoto Hiroaki; Martuza Robert L; Rabkin Samuel D
Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5897-902.
2007: Prabhakar S; Messerli S M; Stemmer-Rachamimov A O; Liu T-C; Rabkin S; Martuza R; Breakefield X O
Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.
Cancer gene therapy 2007;14(5):460-7.
2007: Aghi Manish; Rabkin Samuel D; Martuza Robert L
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Cancer research 2007;67(2):440-4.
2007: Jeyaretna Deva S; Rabkin Samuel D; Martuza Robert L
Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
Neurosurgical focus 2007;22(6):E4.
2006: Liu Ta-Chiang; Zhang Tingguo; Fukuhara Hiroshi; Kuroda Toshihiko; Todo Tomoki; Martuza Robert L; Rabkin Samuel D; Kurtz Andreas
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(6):789-97.
2006: Liu Ta-Chiang; Zhang Tingguo; Fukuhara Hiroshi; Kuroda Toshihiko; Todo Tomoki; Canron Xavier; Bikfalvi Andreas; Martuza Robert L; Kurtz Andreas; Rabkin Samuel D
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6791-9.
2006: Kuroda Toshihiko; Rabkin Samuel D; Martuza Robert L
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Cancer research 2006;66(20):10127-35.
2006: Martuza Robert L
Vestibular schwannoma.
Journal of neurosurgery 2006;105(4):526; discussion 526.
2006: Varghese Susan; Rabkin Samuel D; Nielsen Petur G; Wang Wenzheng; Martuza Robert L
Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2919-27.
2006: Varghese S; Rabkin S D; Liu R; Nielsen P G; Ipe T; Martuza R L
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
Cancer gene therapy 2006;13(3):253-65.
2006: Messerli Shanta M; Prabhakar Shilpa; Tang Yi; Mahmood Umar; Giovannini Marco; Weissleder Ralph; Bronson Rodrick; Martuza Robert; Rabkin Samuel; Breakefield Xandra O
Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.
Human gene therapy 2006;17(1):20-30.
2006: Aghi Manish; Rabkin Samuel; Martuza Robert L
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Journal of the National Cancer Institute 2006;98(1):38-50.
2006: Aghi Manish; Rabkin Samuel; Martuza Robert L
Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
Clinical neurosurgery 2006;53():65-76.
2006: Kuroda Toshihiko; Martuza Robert L; Todo Tomoki; Rabkin Samuel D
Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
BMC biotechnology 2006;6():40.
2005: Fukuhara Hiroshi; Ino Yasushi; Kuroda Toshihiko; Martuza Robert L; Todo Tomoki
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
Cancer research 2005;65(23):10663-8.
2005: Aghi Manish; Martuza Robert L
Oncolytic viral therapies - the clinical experience.
Oncogene 2005;24(52):7802-16.
2005: Fukuhara Hiroshi; Martuza Robert L; Rabkin Samuel D; Ito Yoshikazu; Todo Tomoki
Oncolytic herpes simplex virus vector g47delta in combination with androgen ablation for the treatment of human prostate adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7886-90.
2005: Chan Annie W; Black Peter; Ojemann Robert G; Barker Fred G; Kooy Hanne M; Lopes Vrishali V; McKenna Michael J; Shrieve Dennis C; Martuza Robert L; Loeffler Jay S
Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
Neurosurgery 2005;57(1):60-70; discussion 60-70.
2005: Mashour George A; Walker Erin E; Martuza Robert L
Psychosurgery: past, present, and future.
Brain research. Brain research reviews 2005;48(3):409-19.
2005: Liu R; Martuza R L; Rabkin S D
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
Gene therapy 2005;12(8):647-54.
2005: Mashour George A; Drissel Stephanie N; Frahm Silke; Farassati Faris; Martuza Robert L; Mautner Victor-F; Kindler-Röhrborn Andrea; Kurtz Andreas
Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids.
Oncogene 2005;24(14):2367-74.
2005: Doolittle Nancy D; Abrey Lauren E; Bleyer W Archie; Brem Steven; Davis Thomas P; Dore-Duffy Paula; Drewes Lester R; Hall Walter A; Hoffman John M; Korfel Agnieszka; Martuza Robert; Muldoon Leslie L; Peereboom David; Peterson Darryl R; Rabkin Samuel D; Smith Quentin; Stevens Glen H J; Neuwelt Edward A
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):421-8.
2004: Mashour George A; Driever Pablo Hernáiz; Hartmann Melanie; Drissel Stephanie N; Zhang Tingguo; Scharf Bianca; Felderhoff-Müser Ursula; Sakuma Sadatoshi; Friedrich Reinhard E; Martuza Robert L; Mautner Victor Felix; Kurtz Andreas
Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5677-83.
2004: Kurtz Andreas; Lueth Maria; Kluwe Lan; Zhang Tingguo; Foster Rosemary; Mautner Victor-Felix; Hartmann Melanie; Tan Duan-Jun; Martuza Robert L; Friedrich Reinhard E; Driever Pablo Hernáiz; Wong Lee-Jun C
Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors.
Molecular cancer research : MCR 2004;2(8):433-41.
2003: Weber Damien C; Chan Annie W; Bussiere Marc R; Harsh Griffith R; Ancukiewicz Marek; Barker Fred G; Thornton Allan T; Martuza Robert L; Nadol Joseph B; Chapman Paul H; Loeffler Jay S
Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity.
Neurosurgery 2003;53(3):577-86; discussion 586-8.
2003: Nikolic Boris; Feigenbaum Frank; Abbara Suhny; Martuza Robert L; Schellinger Dieter
CT changes of an intracranial granulocytic sarcoma on short-term follow-up.
AJR. American journal of roentgenology 2003;180(1):78-80.
2002: Kurtz Andreas; Martuza Robert L
Antiangiogenesis in neurofibromatosis 1.
Journal of child neurology 2002;17(8):578-84; discussion 602-4, 646-51.
2001: Jorgensen T J; Katz S; Wittmack E K; Varghese S; Todo T; Rabkin S D; Martuza R L
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.
Neoplasia (New York, N.Y.) 2001;3(5):451-6.
2001: Varghese S; Newsome J T; Rabkin S D; McGeagh K; Mahoney D; Nielsen P; Todo T; Martuza R L
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates.
Human gene therapy 2001;12(8):999-1010.
2001: Todo T; Martuza R L; Rabkin S D; Johnson P A
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(11):6396-401.
2001: Mashour G A; Moulding H D; Chahlavi A; Khan G A; Rabkin S D; Martuza R L; Driever P H; Kurtz A;
Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.
Experimental neurology 2001;169(1):64-71.
2001: Wu A; Mazumder A; Martuza R L; Liu X; Thein M; Meehan K R; Rabkin S D
Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Cancer research 2001;61(7):3009-15.
2001: Toda M; Martuza R L; Rabkin S D
Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
Gene therapy 2001;8(4):332-9.
2001: Mashour G A; Ratner N; Khan G A; Wang H L; Martuza R L; Kurtz A
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Oncogene 2001;20(1):97-105.
2001: Todo T; Martuza R L; Dallman M J; Rabkin S D
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Cancer research 2001;61(1):153-61.
2000: Todo T; Feigenbaum F; Rabkin S D; Lakeman F; Newsome J T; Johnson P A; Mitchell E; Belliveau D; Ostrove J M; Martuza R L
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(6):588-95.
2000: Toda M; Martuza R L; Rabkin S D
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(4):324-9.
2000: Moulding H D; Martuza R L; Rabkin S D
Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(15):5696-702.
2000: Lim D J; Rubenstein A E; Evans D G; Jacks T; Seizinger B G; Baser M E; Beebe D; Brackmann D E; Chiocca E A; Fehon R G; Giovannini M; Glazer R; Gusella J F; Gutmann D H; Korf B; Lieberman F; Martuza R; McClatchey A I; Parry D M; Pulst S M; Ramesh V; Ramsey W J; Ratner N; Rutkowski J L; Ruttledge M; Weinstein D E
Advances in neurofibromatosis 2 (NF2): a workshop report.
Journal of neurogenetics 2000;14(2):63-106.
2000: Todo T; Rabkin S D; Martuza R L
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
Cancer gene therapy 2000;7(6):939-46.
2000: Markert J M; Medlock M D; Rabkin S D; Gillespie G Y; Todo T; Hunter W D; Palmer C A; Feigenbaum F; Tornatore C; Tufaro F; Martuza R L
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
Gene therapy 2000;7(10):867-74.
2000: Sundaresan P; Hunter W D; Martuza R L; Rabkin S D
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice.
Journal of virology 2000;74(8):3832-41.
2000: Sandhu F A; Schellinger D; Martuza R L
A vascular sarcoid mass mimicking a convexity meningioma.
Neuroradiology 2000;42(3):195-8.
2000: Sandhu F A; Martuza R L
Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Journal of neuro-oncology 2000;46(3):241-7.
1999: Mashour G A; Martuza R L; Kurtz A
Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA.
The Journal of investigative dermatology 1999;113(6):1133-4.
1999: Todo T; Rabkin S D; Chahlavi A; Martuza R L
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
Human gene therapy 1999;10(17):2869-78.
1999: Todo T; Rabkin S D; Sundaresan P; Wu A; Meehan K R; Herscowitz H B; Martuza R L
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.
Human gene therapy 1999;10(17):2741-55.
1999: Chahlavi A; Rabkin S; Todo T; Sundaresan P; Martuza R
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.
Gene therapy 1999;6(10):1751-8.
1999: Walker J R; McGeagh K G; Sundaresan P; Jorgensen T J; Rabkin S D; Martuza R L
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.
Human gene therapy 1999;10(13):2237-43.
1999: Mashour G A; Wang H L; Cabal-Manzano R; Wellstein A; Martuza R L; Kurtz A
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1.
The Journal of investigative dermatology 1999;113(3):398-402.
1999: Hunter W D; Martuza R L; Feigenbaum F; Todo T; Mineta T; Yazaki T; Toda M; Newsome J T; Platenberg R C; Manz H J; Rabkin S D
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
Journal of virology 1999;73(8):6319-26.
1999: Chahlavi A; Todo T; Martuza R L; Rabkin S D
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
Neoplasia (New York, N.Y.) 1999;1(2):162-9.
1999: Miyatake S I; Tani S; Feigenbaum F; Sundaresan P; Toda H; Narumi O; Kikuchi H; Hashimoto N; Hangai M; Martuza R L; Rabkin S D
Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo.
Gene therapy 1999;6(4):564-72.
1999: Toda M; Rabkin S D; Kojima H; Martuza R L
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.
Human gene therapy 1999;10(3):385-93.
1998: New K C; Gale K; Martuza R L; Rabkin S D
Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase.
Brain research. Molecular brain research 1998;61(1-2):121-35.
1998: Toda M; Rabkin S D; Martuza R L
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
Human gene therapy 1998;9(15):2177-85.
1998: Toda M; Martuza R L; Kojima H; Rabkin S D
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(9):4457-64.
1997: Miyatake S; Martuza R L; Rabkin S D
Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
Cancer gene therapy 1997;4(4):222-8.
1997: Miyatake S; Iyer A; Martuza R L; Rabkin S D
Transcriptional targeting of herpes simplex virus for cell-specific replication.
Journal of virology 1997;71(7):5124-32.
1996: Yazaki T; Martuza R L; Rabkin S D
Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration.
Brain research. Molecular brain research 1996;43(1-2):311-20.
1996: Yazaki T; Ahmad S; Chahlavi A; Zylber-Katz E; Dean N M; Rabkin S D; Martuza R L; Glazer R I
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Molecular pharmacology 1996;50(2):236-42.
1995: Yazaki T; Manz H J; Rabkin S D; Martuza R L
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.
Cancer research 1995;55(21):4752-6.
1995: Mineta T; Rabkin S D; Yazaki T; Hunter W D; Martuza R L
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
Nature medicine 1995;1(9):938-43.
1995: Yazaki T; Takamiya Y; Costello P C; Mineta T; Menon A G; Rabkin S D; Martuza R L
Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.
Journal of neuro-oncology 1995;23(1):23-9.
1994: al-Nabulsi I; Takamiya Y; Voloshin Y; Dritschilo A; Martuza R L; Jorgensen T J
Expression of thymidine kinase is essential to low dose radiation resistance of rat glioma cells.
Cancer research 1994;54(21):5614-7.
1994: Ahmad S; Mineta T; Martuza R L; Glazer R I
Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cells.
Neurosurgery 1994;35(5):904-8; discussion 908-9.
1994: Mineta T; Rabkin S D; Martuza R L
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.
Cancer research 1994;54(15):3963-6.
1994: Takamiya Y; Brem H; Ojeifo J; Mineta T; Martuza R L
AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.
Neurosurgery 1994;34(5):869-75; discussion 875.
1994: New K C; Martuza R L; Rabkin S D
Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS.
Gene therapy 1994;1 Suppl 1():S79.
1994: Mineta T; Markert J M; Takamiya Y; Coen D M; Rabkin S D; Martuza R L
CNS tumor therapy by attenuated herpes simplex viruses.
Gene therapy 1994;1 Suppl 1():S78.
1993: Takamiya Y; Short M P; Moolten F L; Fleet C; Mineta T; Breakefield X O; Martuza R L
An experimental model of retrovirus gene therapy for malignant brain tumors.
Journal of neurosurgery 1993;79(1):104-10.
1993: Markert J M; Malick A; Coen D M; Martuza R L
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir.
Neurosurgery 1993;32(4):597-603.
1992: Takamiya Y; Short M P; Ezzeddine Z D; Moolten F L; Breakefield X O; Martuza R L
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
Journal of neuroscience research 1992;33(3):493-503.
1992: Markert J M; Coen D M; Malick A; Mineta T; Martuza R L
Expanded spectrum of viral therapy in the treatment of nervous system tumors.
Journal of neurosurgery 1992;77(4):590-4.
1991: Martuza R L; Malick A; Markert J M; Ruffner K L; Coen D M
Experimental therapy of human glioma by means of a genetically engineered virus mutant.
Science (New York, N.Y.) 1991;252(5007):854-6.
1991: Fontaine B; Sanson M; Delattre O; Menon A G; Rouleau G A; Seizinger B R; Jewell A F; Hanson M P; Aurias A; Martuza R L
Parental origin of chromosome 22 loss in sporadic and NF2 neuromas.
Genomics 1991;10(1):280-3.
1991: Fontaine B; Hanson M P; VonSattel J P; Martuza R L; Gusella J F
Loss of chromosome 22 alleles in human sporadic spinal schwannomas.
Annals of neurology 1991;29(2):183-6.
1991: Fontaine B; Rouleau G A; Seizinger B R; Menon A G; Jewell A F; Martuza R L; Gusella J F
Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma).
Annals of the New York Academy of Sciences 1991;615():338-43.
1990: Fontaine B; Rouleau G A; Seizinger B; Jewell A F; Hanson M P; Martuza R L; Gusella J F
Equal parental origin of chromosome 22 losses in human sporadic meningioma: no evidence for genomic imprinting.
American journal of human genetics 1990;47(5):823-7.
1990: Jacoby L B; Hedley-Whyte E T; Pulaski K; Seizinger B R; Martuza R L
Clonal origin of pituitary adenomas.
Journal of neurosurgery 1990;73(5):731-5.
1990: Jacoby L B; Pulaski K; Rouleau G A; Martuza R L
Clonal analysis of human meningiomas and schwannomas.
Cancer research 1990;50(21):6783-6.
1990: Rouleau G A; Seizinger B R; Wertelecki W; Haines J L; Superneau D W; Martuza R L; Gusella J F
Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
American journal of human genetics 1990;46(2):323-8.
1987: Rouleau G A; Wertelecki W; Haines J L; Hobbs W J; Trofatter J A; Seizinger B R; Martuza R L; Superneau D W; Conneally P M; Gusella J F
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.
Nature 1987;329(6136):246-8.
1987: Seizinger B R; Martuza R L; Rouleau G; Breakefield X O; Gusella J F
Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis.
Developmental neuroscience 1987;9(3):144-53.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Martuza

Research Profile (preview)

Living Beings

Procedures

Chemicals & Drugs

Physiology

Anatomy

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Martuza (preview)

All Publications